Navigation Links
Shareholders Demand Philip Morris USA Stop Interfering in Health Policy
Date:5/28/2008

RICHMOND, Va., May 28 /PRNewswire-USNewswire/ -- At today's Altria (Philip Morris USA) annual meeting, shareholders demanded that the corporation stop lobbying against public health and tobacco control measures. America's largest tobacco corporation is opposing the Smuggled Tobacco Prevention (STOP) Act recently introduced in the U.S. House of Representatives (H.R. 5689), which contains new and stronger requirements on labeling, tracking and reporting by the tobacco industry.

This is the corporation's first annual meeting since it spun off its international tobacco business in March. PM USA executives are predicting that the split will reverse the revenue and operating profits decline of the last seven years.

"While executives continue to calculate how to build new fortunes for Philip Morris USA, our members continue to demand that the corporation stop promoting addictive, deadly products like Marlboro and Virginia Slims to our kids," said Tom Gaffney, spokesperson for Corporate Accountability International in a statement to Altria Chair and CEO Michael Szymanczyk.

On May 31, Gaffney's organization is joining the World Health Organization's (WHO) "World No Tobacco Day," which urges action to reverse a preventable epidemic that kills 5.4 million people each year. This year's event calls for a ban on tobacco advertising, promotion and sponsorship. Such a ban is one of the provisions of the WHO global tobacco treaty that now binds more than 150 countries.

The Bush Administration signed the global tobacco treaty four years ago, during the last U.S. Presidential election campaign, but has yet to submit it to the Senate for ratification.

"Big Tobacco's political influence is the single greatest obstacle to effective tobacco control policy in the U.S. and around the world," said Gaffney.

Prior to its breakup, in 2006 Philip Morris/Altria had three registered lobbyists in Washington for every five U.S. Senators. In the first quarter of this year, the corporation spent $3 million lobbying on a range of public health, tobacco control and regulatory measures.

For more than 15 years, Corporate Accountability International has pressured Big Tobacco to decrease its influence-peddling on Capitol Hill and stop interfering in life-saving policies. And despite its reluctance to do so, what was once the world's largest and most profitable tobacco corporation has changed its name, broken into three pieces, been subject to Congressional hearings, paid out millions in settlements and closed its New York City headquarters.

Corporate Accountability International, formerly Infact, is a membership organization that protects people by waging and winning campaigns challenging irresponsible and dangerous corporate actions around the world. For over 25 years, we've forced corporations -- like Nestle, General Electric and Philip Morris/Altria -- to stop abusive actions. Corporate Accountability International, an NGO in Official Relations with the World Health Organization (WHO), played a key role in development of the FCTC. For more information visit http://www.StopCorporateAbuse.org.

Contact

Sara Joseph, 617-447-2527, SJoseph@StopCorporateAbuse.org

Nick Guroff, 617-447-2507, NGuroff@StopCorporateAbuse.org


'/>"/>
SOURCE Corporate Accountability International
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
2. Zimmer Holdings Offer and ORTHOsoft Directors Circular Mailed to Shareholders
3. Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting
4. United Medicorp, Inc.s Shareholders Approve All Proposals
5. Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Directors
6. Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex
7. Arrow International, Inc. Invites You to Join Its 2007 Annual Meeting of Shareholders on the Web
8. Flextronics Shareholders and Solectron Stockholders Approve Acquisition
9. Healthcare Technologies to Reschedule the Shareholders Meeting to Approve the NexGen Biofuels Transaction
10. Lafley Tells Shareholders That P&G is Designed to Grow
11. Manor Care Shareholders Vote to Approve $6.3 Billion Carlyle Buyout
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... February 17, 2017 , ... For ... assistance management solution to the exhibit floor for the 2017 HIMSS Conference ... , From Feb. 19–23, 2017, more than 40,000 healthcare industry professionals are expected ...
(Date:2/17/2017)... Seattle, WA (PRWEB) , ... February 17, 2017 ... ... health management organizations, has been named a finalist in the 8th Annual DecisionHealth ... impacting America's healthcare delivery system. Qualis Health’s work is recognized across multiple award ...
(Date:2/17/2017)... ... 2017 , ... Pharmica Consulting attended CHI's 8th Annual SCOPE ... trial planning and management. Pharmica discussed the importance of effective project management, data ... by Pharmica’s booth were able to demo its cloud-based Resource Management Tool, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Top neuroendocrine cancer doctors, nurses and specialists from ... February 21 - 23 in Beaver Creek, CO. It was announced today by Cindy ... year in Beaver Creek, hosting over 60 faculty members and addressing unmet needs of ...
(Date:2/16/2017)... ... 17, 2017 , ... For some cancer survivors, the memories ... Physician researchers at The Marcus Institute of Integrative Health at Thomas Jefferson ... reducing symptoms of traumatic stress in cancer patients and published their results ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... 17, 2017  Noble Capital Markets announced today that ... (Nasdaq: EPIX ). The report was issued ... , PhD. ESSA Pharmaceuticals is a clinical ... cancer (CRPC). Its lead compound EPI-506, is a small ... of the androgen receptor, thereby has potential to overcome ...
(Date:2/16/2017)... Quest Diagnostics (NYSE: DGX ), ... announced that it has been named one of the ... The annual survey designated Quest Diagnostics as ... Pharmacy and Other Services" industry to attain Most Admired ... attain the designation. This is the second consecutive year ...
(Date:2/16/2017)... Feb. 16, 2017  Aralez Pharmaceuticals Inc. (NASDAQ: ... company, today announced that executive management will participate in ... held February 22-23, 2017. Adrian Adams , Chief ... at 1:35 p.m. local time on Wednesday, February 22, ... for the event may be accessed from the Investors ...
Breaking Medicine Technology: